Search Government Hematology Devices Contracts for Bid in Montreal (Territory Equivalent)

GovWin IQ: Find and Win Government Contracts

GovWin IQ tracked 6 hematology devices contracts that came up for bid by government agencies in Montreal (Territory Equivalent) in a one year period.

Sample Hematology Devices Contracts to Bid in Montreal (Territory Equivalent)

Government Agency Type Description Location Contact
QUEBEC » CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CANADA) BID Blood apheresis system acquisition, accessories and training Montreal (Territory Equivalent) Try GovWin IQ for Free
QUEBEC BID Acquisition of a flow cytometry device for the Center of Excellence in Cell Therapy Montreal (Territory Equivalent) Try GovWin IQ for Free
QUEBEC BID ACQUISITION OF COAGULATION ANALYZER Montreal (Territory Equivalent) Try GovWin IQ for Free
QUEBEC BID Acquisition of apheresis equipment Montreal (Territory Equivalent) Try GovWin IQ for Free
QUEBEC » CORPORATION DE L'ECOLE POLYTECHNIQUE DE MONTREAL (CANADA) BID PALA compact cell sorter and single cell dispenser system Montreal (Territory Equivalent) Try GovWin IQ for Free
QUEBEC BID ACQUISITIONS OF APHERESIS SYSTEMS Montreal (Territory Equivalent) Try GovWin IQ for Free

Learn More About GovWin IQ for Montreal (Territory Equivalent) Service Providers

GovWin IQ from Deltek is the industry-leading platform providing the most comprehensive market intelligence for U.S. federal, state, local and Canadian governments. GovWin IQ is uniquely built, backed and continuously updated by award-winning industry experts who receive first-hand intelligence from government decision-makers. With this intelligence, GovWin IQ enables companies to identify early stage opportunities, plan strategically, build relationships and navigate the competitive landscape. See why thousands of companies rely on GovWin IQ to get ahead of the competition and win more business in the public sector. Deltek.com/GovWin

To learn more about GovWin IQ's solutions for hematology devices vendors, click here.